Life Sciences: IP/Patent Litigation | USA

William Lee has an exceptionally impressive track record in the representation of technology and life sciences organizations in high profile intellectual property trials and appeals. He offers substantial experience in matters relating to pharmaceuticals, medical devices and genetic engineering.

Catherine Polizzi maintains a broad practice in the field of intellectual property which encompasses Freedom to Operate assessments, portfolio management and patent applications, as well as diligence in high-value acquisitions.

David Gindler is global co-leader of Orrick Herrington & Sutcliffe’s life sciences and healthtech sector. He offers extensive experience in litigation and intellectual property licensing matters, with clients including emerging businesses, established corporations and nonprofits.

Elizabeth Stotland Weiswasser is cochair of the litigation department at Paul, Weiss, Rifkind, Wharton & Garrison. She is frequently called upon to handle complex patent disputes on behalf of leading life sciences companies. She is well versed in a variety of contentious matters and regularly appears before the PTAB, ITC and district courts.

Michael Morin is global chair of intellectual property litigation practice at Latham & Watkins. He is known for his extensive representations of large pharmaceutical companies in connection with patent and copyright infringement matters.

Ching-Lee Fukuda is co-leader of global IP litigation practice at Sidley Austin. She is an experienced IP litigator who frequently works with leading life sciences companies on major patent disputes, including before the ITC and PTAB.

Edward Reines is noted for his work representing life sciences companies in contentious IP matters, both at trial and appeal. He regularly appears before both district and federal courts.

Janet Xiao is a notable patent attorney who represents biopharmaceutical companies in cross border patent procurement, portfolio management and intellectual property strategic planning.